Summary
A medRxiv preprint reports that repeated odour cues delivered during sleep improved PTSD symptoms and accelerated treatment response when paired with 12 weeks of trauma-focused psychotherapy. The findings combine a mechanistic study in healthy participants with a randomized clinical trial.
A preprint study reports that delivering a therapy-associated odour during sleep may strengthen the effects of trauma-focused psychotherapy for people with post-traumatic stress disorder (PTSD). The research combined a mechanistic study in healthy participants with a randomized clinical trial in patients with PTSD.
The study was posted on medRxiv on September 15, 2026. As a preprint, it is early clinical evidence rather than a completed peer-reviewed publication.
How odour cueing was used
The researchers used targeted memory reactivation (TMR), an approach in which a cue linked to learning or therapy is presented again during sleep. The aim is to engage sleep-dependent memory consolidation—the process through which recently formed memories are stabilised and integrated.
In the mechanistic part of the study, healthy participants were re-exposed during sleep to an odour associated with therapy. The researchers measured slow-wave activity, slow oscillations and the relationship between slow oscillations and sleep spindles. Slow oscillations and spindles are characteristic patterns of brain activity during non-rapid-eye-movement sleep and are commonly studied in relation to memory processing.
The clinical part involved repeated odour cueing during sleep throughout 12 weeks of trauma-focused treatment for patients with PTSD. The intervention was therefore tested as an addition to psychotherapy, rather than as a replacement for it.
What the study found
Among the healthy participants, odour re-exposure during sleep increased slow-wave activity and slow oscillations. Larger increases in slow-oscillation–spindle coupling were associated with lower emotional arousal when participants later recalled aversive autobiographical memories. This finding links the sleep-related brain response with emotional memory processing, although the association alone does not establish that the coupling caused the reduction in arousal.
In the randomized clinical trial, the researchers reported improvements in both clinician-rated and self-reported PTSD symptoms when sleep cueing accompanied trauma-focused treatment. The strongest reported changes involved re-experiencing and negative alterations in cognition and mood. The researchers also reported faster treatment response and remission.
The findings are meaningful because trauma-focused psychotherapy works partly by helping patients update traumatic memories with safer, more adaptive representations, yet clinically meaningful improvement is not achieved by every patient. A low-intensity sleep-based cue could, if the results are replicated, become an adjunct intended to reinforce the memory changes targeted during therapy.
The preprint’s abstract reports the direction of the clinical findings but does not provide participant numbers, numerical effect estimates or detailed comparator information. It also does not establish how long the reported benefits persist or whether the approach would work outside the structured 12-week treatment setting. The proposed explanation is that odour cueing supports sleep-dependent memory consolidation, with the healthy-participant and patient findings providing converging evidence for that possibility.